PRIME VACCINE
Aeg29-1008	The Rusty Nail Lie: The Toxic Tetanus Shot You Dont Need
	Quote:	Your actual chance of contracting tetanus in a clean country is approximately 1 in 11 million. From 2009 to 2023, there were only 402 reported cases in the entire United States, and a significant portion of those cases were in unvaccinated individuals with poor wound care. You have a better chance of being struck by lightning multiple times.... Tetanus spores cannot establish themselves in a wound that is clean, bleeding, and exposed to oxygen. A clean, bleeding wound physically flushes out spores and allows oxygen to neutralize the threat. 95 of the decline in tetanus deaths happened before the widespread use of the vaccine, thanks to sanitation and hygienenot the needle.... The shot is useless anyway. The vaccine is a toxoid; it requires 3 to 8 weeks for your immune system to develop antibodies. Tetanus has an incubation period of 3 to 21 days. By the time you build immunity, you are either dead or recovering.
	Comment:	Indeed, the shot is useless for the current exposure, if any. And Dr. Klenner showed that Vitamin C will cure Tetnus.
	Article:	https://principia-scientific.com/the-rusty-nail-lie-the-toxic-tetanus-shot-you-dont-need/
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
COVID-19 VACCINE VIRUS
Bim29-011	A human monoclonal antibody from hybrid immunity exhibits exceptional neutralization breadth against antigenically divergent contemporary Omicron JN.1 lineage variants
	Article:	https://www.biorxiv.org/content/10.64898/2026.07.20.739483v1
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Diwakar Rathour Shweta Shrivas Naresh Kumar Chaman Prasad Janmejay Singh Gagandeep Singh A. Surendranath Shweta Rathi Sneha Verma Supriya Chauhan Balwant Singh Jyoti Sutar Souvick Chattopadhyay Gaurav Batra Sudipta Sonar Isabella Eckerle Lorenzo Subbissi Anant Mohan Shailendra Asthana Suprit Deshpande JAYANTA BHATTACHARYA,
PRIME COVID-19 VACCINE VIRUS
Mep29-005	Epidemic dynamics shape variant appearance and stochastic establishment: implications for vaccination
	Quote:	The relationship between the escape pressure and the vaccination coverage depends on the cross-immunity, due to susceptible depletion. For example, with intermediate cross-immunity, the risk of immune escape may be lowest at intermediate vaccination coverages. Thus, these results raise important considerations for vaccination strategies in response to novel outbreaks.
	Comment:	The mathematics suggest their conclusion: Intermediate levels of cross immunity have the lowest rate in which the virus evolves to create new variants which may compete with the original for hosts, aka victims.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.07.21.26358562v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.07.21.26358562v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Maria A. Gutierrez Julia Rose Gog,
PRIME COVID-19 EYES VACCINE
Zzg29-1005	Evaluation of the Effects of mRNA-COVID 19 Vaccines on Corneal Endothelium
	Quote:	Conclusion: Changes in corneal endothelium occur in the short term after two-doses of the Pfizer-BioNTech (BNT162b2) COVID-19 mRNA vaccine. Hence the endothelium should be closely monitored in those with a low endothelial count or who have had a corneal graft.
	Article:	https://pubmed.ncbi.nlm.nih.gov/40658089/
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho

Javilk's Research Links Newsletter for Week 29
Updated 07/25/2026-03:15:16 AM
What interests you? What have you found? Tell me!
Drop me a note to subscribe or submit something.

Aeg29-1008

The Rusty Nail Lie: The Toxic Tetanus Shot You Dont Need

Bim29-011

A human monoclonal antibody from hybrid immunity exhibits exceptional neutralization breadth against antigenically divergent contemporary Omicron JN.1 lineage variants

Mep29-005

Epidemic dynamics shape variant appearance and stochastic establishment: implications for vaccination

Zzg29-1005

Evaluation of the Effects of mRNA-COVID 19 Vaccines on Corneal Endothelium